BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME:www.indybay.org
PRODID:-//indybay/ical// v1.0//EN
BEGIN:VEVENT
UID:Indybay-18779085
SEQUENCE:18903927
CREATED:20151020T211100Z
DESCRIPTION:A New Understanding: The Science of Psilocybin explores the treatment of 
 end-of-life anxiety in terminally ill cancer patients using psilocybin, a 
 psychoactive compound found in some mushrooms, to facilitate deeply 
 spiritual experiences. The documentary explores the convergence of science 
 and spirituality in the first psychedelic research studies with terminally 
 ill patients since the 1970s.\n\nAs a society we devote a great deal of 
 attention to treating cancer, but very little to treating the human being 
 who is dying of cancer. A New Understanding: The Science of Psilocybin 
 shows patients and their families coming to terms with dying through the 
 skillful treatment of the whole human being.\n\n\nRobert J. Barnhart has a 
 BA in comparative religion from Emory University in Atlanta, GA. He has 
 been a strong advocate for the study of psychoactive materials in spiritual 
 and non-traditional healing practices for many years. He sits on the board 
 of both The Heffter Research Institute and The Multi-Disciplinary 
 Association for Psychedelic Studies. He further sits on the board of COSM, 
 supporting the visionary art work of Alex Grey.\nMr. Barnhart is active 
 caring for the well-being of our planet's environmental ecosystem. He has 
 now completed producing this documentary film about the use of psilocybin 
 medicine in modern healing practices. He currently lives in Austin, Texas 
 where he enjoys being a father to his ten year old daughter.\n\n\nJeffrey 
 Guss, M.D., is a psychiatrist and psychoanalyst with specialization in 
 addictive disorders and psychotherapy. He is Co-Principal Investigator and 
 the Director of Therapist Training for the  NYU Psilocybin Cancer Anxiety 
 Project.  Dr. Guss is developing a model for training therapists for cancer 
 related therapy trials, as well as imagining clinical practice with 
 psilocybin-assisted therapy. He maintains a psychotherapy based practice in 
 New York City and is a graduate of the NYU Postdoctoral Program in 
 Psychotherapy and Psychoanalysis.\n\n\nStephen Ross, M.D., is Associate 
 Professor of Psychiatry and Child & Adolescent Psychiatry at the New York 
 University (NYU) School of Medicine and Associate Professor of Oral and 
 Maxillofacial Pathology, Radiology and Medicine at the NYU College of 
 Dentistry. He is the Director of the Division of Alcoholism and Drug Abuse 
 at Bellevue Hospital Center, Director of Addiction Psychiatry at NYU 
 Langone Medical Center/Tisch Hospital, and the Director of the NYU 
 Addiction Fellowship. Dr Ross directs an NIH funded Addictive Disorders 
 Laboratory at Bellevue Hospital Center and is the Director of the NYU 
 Psychedelic Research Group. Dr Ross researches the therapeutic application 
 of hallucinogen treatment models to treat psychiatric and addictive 
 disorders. He is an expert in psycho-oncology and is studying novel 
 pharmacologic-psychosocial approaches to treating psychological distress 
 associated with advanced or terminal cancer. He is the Principal 
 Investigator (PI) of the NYU Psilocybin Cancer Project (a recently 
 completed FDA phase II RCT studying the efficacy of psilocybin-assisted 
 psychotherapy in patients with life-threatening cancer and 
 psychological/existential distress), PI of a controlled trial administering 
 psilocybin to religious professionals, and co-PI of a controlled trial 
 assessing psilocybin-assisted psychotherapy in patients with alcoholism. 
 Dr. Ross receives his research funding from the National Institute on Drug 
 Abuse (NIDA), the NYU School of Medicine and the Heffter Research 
 Institute.\n\n\nCharles S. Grob, M.D., is Director of the Division of Child 
 and Adolescent Psychiatry at Harbor-UCLA Medical Center, and Professor of 
 Psychiatry and Pediatrics at the UCLA School of Medicine.  Dr. Grob 
 conducted the first government approved psychobiological research study of 
 MDMA, and was the principal investigator of an international research 
 project in the Brazilian Amazon studying the visionary plant brew, 
 ayahuasca.  He has also completed and published the first approved research 
 investigation in several decades on the safety and efficacy of psilocybin 
 treatment in terminal cancer patients with anxiety, and is currently 
 studying the use of MDMA in the treatment of autistic adults with social 
 anxiety.  Dr. Grob is the editor of Hallucinogens: A Reader 
 (Tarcher/Putnam, 2002) and co-editor (with Roger Walsh) of Higher Wisdom: 
 Eminent Elders Explore the Continuing Impact of Psychedelics (SUNY Press, 
 2005).  He is also a founding board member of the Heffter Research 
 Institute.\n https://www.indybay.org/newsitems/2015/10/20/18779085.php
SUMMARY:"A New Understanding: The Science of Psilocybin" a film by Robert J. Barnhart
LOCATION:California Institute of Integral Studies - CIIS Main Building\n1453 Mission 
 Street\nNamaste Hall, 3rd Floor\nSan Francisco, CA 94103
URL:https://www.indybay.org/newsitems/2015/10/20/18779085.php
DTSTART:20151114T030000Z
DTEND:20151114T050000Z
END:VEVENT
END:VCALENDAR